ProBioGen AG’s Post

Imagine being able to produce robust and stable high-titer lentiviral vectors for cell manufacturing. 💭 The traditional method of transient transfection is complex and costly. Using packaging cell lines as a production platform, you can produce your lentiviruses efficiently, cost-effectively, and most importantly, reliably. 💪 We show you the way, either with our licensable Lenti.RiGHT® production platform for your in-house work or as a CDMO partner for Design and GMP-Manufacturing of your lentiviral vectors.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics